Showing 691-700 of 4263 results for "".
Using Dermoscopy For Improved Clinical Decisions
https://practicaldermatology.com/conferences/maui-derm-2024/using-dermoscopy-for-improved-clinical-decisions/20264/Resident Of Distinction Award-winner Chloe Fernandez, DO, PGY-2 resident at the ADCS Orlando Dermatology Program, reviews a presentation on dermoscopy in special sites such as the palms, soles, and face, and talks about its importance to both her personal training as well as the benefits for patientHow New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approaches-to-ak-management/20133/When confronted with AK, dermatologists are armed with various treatment options, including destructive and field-directed therapies. Vishal Patel, MD and Neal Bhatia, MD talk about their approach to decision-making.Cosmetic Controversies: A CSF Update from the 2019 Meeting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-controversies-a-csf-update/20121/Some of the leading minds in cosmetic surgery weigh in on the ongoing controversies in aesthetic patient care. David Goldberg, MD, JD, Zakia Rhaman, MD, Hema Sundaram, MD, and Julie Woodward, MD talk lasers, injectables, and influencers.Blue Light: A Different Take
https://practicaldermatology.com/topics/acne-rosacea/blue-light-a-different-take/20088/Targeted blue light can have beneficial effects on the skin, says Terrence Keaney, MD. He discusses the types of questions he gets from patients about blue light and what the current data show about the efficacy of low-energy at-home blue light treatments, particularly for acne.Acne Treatment Strategies
https://practicaldermatology.com/conferences/maui-derm-2022/acne-treatment-strategies/20046/Guy F. Webster, MD, PhD shares acne management strategies that are effective for patients and help minimize use of antibiotics. He also discusses the continued role for isotretinoin for the right candidates.Advances in Wound Care
https://practicaldermatology.com/conferences/maui-derm-2022/maui-derm-2022-video/20040/Robert S. Kirsner, MD, PhD discusses the latest in wound healing science and resulting changes in how leading wound care experts are approaching patient care. From innovative products to greater understanding of the science, there are many options to help patients heal.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitMake Your Mark: Formulate a Product Line
https://practicaldermatology.com/topics/practice-management/make-your-mark-formulate-a-product-line/20023/Dispensing skincare offers benefits to your practice and your patients. Joel Schlessinger, MD discusses his journey with his son to developing their own product formulation and offers insights and encourages colleagues to use their unique talents to do the same.